[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558639":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":20,"responsibleParty":33,"collaborators":7,"id":35,"slug":36,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":7,"eligibilityCriteria":41,"healthyVolunteers":37,"sex":42,"minAge":43,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":7,"overallStatus":53,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"European Institute of Oncology","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Giuseppe Testa","PRINCIPAL_INVESTIGATOR",[13,17],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+39 02 9437 5105","giuseppe.testa@ieo.it",{"name":18,"role":14,"phone":7,"phoneExt":7,"email":19},"Pietro Lo Riso","pietro.loriso@ieo.it",[21],{"facility":5,"status":7,"city":22,"state":7,"zip":7,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Milan","Italy","IT",{"type":26,"coordinates":27},"Point",[28,29],9.18951,45.46427,{"lat":29,"lon":28},[32],{"name":10,"role":14,"phone":7,"phoneExt":7,"email":7},{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100558639","high-definition-profiling-of-ovarian-cancer-ascites-100558639",false,"NCT06553742","High Definition Profiling of Ovarian Cancer Ascites","High Definition Profiling of Ovarian Cancer Ascites for the Identification of Prognostic Biomarkers and Immunotherapeutic Targets: an Integrative Cell of Origin-guided Approach","Inclusion Criteria:\n\n* Patients with suspicious or confirmed ovarian cancer pathology undergoing debulking surgery\n* Diagnosis of high grade serous ovarian cancer confirmed by histopathology assessment\n* Patients who provided written informed consent\n\nExclusion Criteria:\n\n* HIV-positive patients\n* HBV-positive patients\n* HCV-positive patients","FEMALE","18 Years",{"count":45,"type":46},50,"ESTIMATED","OBSERVATIONAL","This project entails the collection of a prospective cohort of ascites (AS) samples from High Grade Serous Ovarian Cancer (HGSOC) patients.\n\nHigh Grade Serous Ovarian Cancer (HGSOC) is a major cause of cancer-related mortality, due to the late-stage diagnosis and failure of surgery and chemotherapy (CHT) to eradicate the disease with no significant improvement in overall survival.\n\nThe primary objective of the project is to generate a comprehensive map of ascites cell components, detailing both their intrinsic features and the landscape of cellular interactions mediated by soluble factors in ascitic fluid.",[50,51,52],"Ovarian Cancer","High Grade Ovarian Serous Adenocarcinoma","Ascites","NOT_YET_RECRUITING","2024-11-18",{"date":56,"type":57},"2024-11-20","ACTUAL",{"date":59,"type":46},"2024-11",{"date":61,"type":46},"2033-12",{"name":5,"class":6},1]